Çocukluk Çağı Hodgkin Lenfoma Nedeniyle Tedavi Gören Hastalarda Tiroid Fonksiyonlarının Değerlendirilmesi

Öz

Amaç: Çocukluk çağı Hodgkin Lenfoma tedavisinde sağkalım oran ve süresi uzadıkça, tedavi sonucu gelişen yan etkilerin görülme sıklığı artmakta ve tedavinin geç etkileri giderek önem kazanmaktadır. Bu çalışmada çocukluk çağında Hodgkin Lenfoma nedeniyle tedavi gören hastalarda, kemoterapi ve radyoterapinin tiroid fonksiyonları üzerine geç yan etkilerinin değerlendirilmesi amaçlandı. Yöntem: İstanbul Sağlık Bilimleri Üniversitesi, Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi, Çocuk Hematoloji ve Onkoloji Kliniği’nde, 1994-2013 yılları arasında Hodgkin Lenfoma tanısı ile tedavi görüp, remisyonda olarak izlenen, en az 6 aydır tedavi almayan, 34’ü erkek, 6’sı kız olmak üzere toplam 40 hastanın tiroid fonksiyonları retrospektif olarak incelendi. Bulgular: Tanı alan hastaların yaş ortalaması 14.13±6.081 dağılım: 4-31 , erkek/kız oranı 34/6 %85/%15 idi. Ortalama takip süresi 5.54±3.68 yıl 0,92-13,92 idi. Tüm hastalara kemoterapi verildi. Boyun bölgesine radyoterapi 37 hasta %92,5 almıştı. Ortalama radyoterapi dozu 21.4875±4.48726 Gy idi. Hastalarımızda %72.5 oranında primer hastalık baş-boyun bölgesine lokalize idi. B semptomu 7 hastada %17,5 vardı. Kırk hastanın 12’inde %30 hasta hipotiroidi saptandı, 5 hastaya %41 klinik hipotiroidi tanısıyla replasman tedavisine başlandı. Bu hastaların 11’i erkek %91 , 1’i kızdı %9 . Hastalarımızın 5’inde %12.5 yapılan tiroid USG’sinde tiroid bezi nodülü saptandı. Tiroid nodülü saptanan toplam 5 hastanın 3’ü erkek %60 , 2’si kızdı %40 . Hipotiroidi gelişme zamanı 3.10±2.02 yıl, tiroid nodülü oluşma zamanı 8.90±7.10 yıl olarak saptandı. Tiroid sintigrafisi ve tiroid ultrasonografi sonuçlarına göre seçilen üç hasta tiroid biyopsisine yönlendirildi, malinite saptanmadı. Sonuç: Pediatrik Hodgkin Lenfoma hastalarında radyasyona bağlı tiroid hastalıkları, tedaviden sonraki yıllarda, hastalık remisyonda iken gelişebilir. Özellikle boyun radyoterapisine maruz kalmış hastalar, tiroid fonksiyon bozukluklarının ortaya çıkması açısından yakından takip edilmelidir

Anahtar Kelimeler

• Hodgkin Lenfoma, çocukluk çağı, kemoterapi, tiroid, geç yan etki

Evaluation of Thyroid Functions in Patients Treated Pediatric Hodgkin Lymphoma

Öz

Objective: As the survival rate and duration increases in the treatment of childhood Hodgkin’s Lymphoma, the incidence of side effects resulting from the treatment increases and the late effects of the treatment become increasingly important. The aim of this study was to evaluate the late side effects of chemotherapy and radiotherapy on thyroid functions in patients treated for Hodgkin’s Lymphoma in childhood. Method: Thyroid functions of 40 patients who were treated with diagnosis of Hodgkin’s Lymphoma, between 1994 and 2013, followed up in remission in Istanbul Health Sciences University, Kanuni Sultan Süleyman Training and Research Hospital, Department of Pediatric Hematology and Oncology, were evaluated retrospectively. Results: The mean age of the patients was 14.13±6.081 range: 4-31 years, and the male / female ratio was 34/6 85%/15% . The mean follow-up period was 5.54±3.68 years 0.92-13.92 . All patients received chemotherapy. Thirty seven patients 92.5% received radiotherapy to the neck region. The mean radiotherapy dose was 21.4875±4.48726 Gy. Primary disease was localized to head and neck region in 72.5% of our patients. B symptoms were present in 7 patients 17.5% . Hypothyroidism was detected in 12 of 40 patients 30% and replacement therapy was started in 5 patients 41% with the diagnosis of clinical hypothyroidism. Eleven 91% of these patients were male and 1 9% was female. Thyroid gland nodules were detected in 5 12.5% of our patients. Of 5 patients with thyroid nodules, 3 were male 60% and 2 were female 40% . Hypothyroidism was 3.10±2.02 years and thyroid nodule was 8.90±7.10 years. Three patients who were selected according to thyroid scintigraphy and thyroid ultrasonography results were referred to thyroid biopsy and no malignancy was detected. Conclusion: Radiation-induced thyroid diseases in pediatric Hodgkin’s Lymphoma patients may develop during the years following treatment, when the disease is in remission. In particular, patients exposed to neck radiotherapy should be closely monitored for the occurrence of thyroid dysfunction.

Anahtar Kelimeler

• Hodgkin’s Lymphoma, childhood, chemotherapy, thyroid, late side effect

Kaynakça

1. 1. Hudson MM, Onciv M, Donaldson SS. Hodgkin lymphoma. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott Williams and Wilkins; 2006. pp. 695-721.
2. 2. Hodgkin Lymphoma. In: Lanzkowsky P. Manuel of pediatric hematology and oncology. Burlington: Elsevier Academic Press; 2005. pp. 453-490.
3. 3. Bhatia S, Blatt J, Meadows AT. Late effects of childhood cancer and its treatment. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott Williams and Wilkins; 2006. pp. 1490-1514.
4. 4. Kutluk T. First Pediatric Cancer Registry in Turkey. A Turkish Pediatric Oncology Group (TPOG) Study Med. And Ped. Oncol. 2004;43:452.
5. 5. Poyrazoğlu Ş, Baş F, Darendeliler E, Darendeliler F. Çocukluk çağı kanser tedavisinin endokrin geç yan etkileri. Türk Onkoloji Dergisi 2010;25(1):37-46.
6. 6. Sklar C, Whitton J, Mertens A, Stovall M, Green D, Marina N, Greffe B, et al. Abnormalities of the thyroid in survivors of Hodgkin’s disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab. 2000;85:3227-32. https://doi.org/10.1210/jc.85.9.3227
7. 7. Brusamolino E, Lunghi F, Orlandi E, Astori C, Passamonti F, BaratO˜ C, Pagnucco G, Baio A, Franchini P, Lazzaroni M et al. Treatment of early-stage Hodgkin’s disease with four cycles of ABVD followed by adjuvant radiotherapy: analysis of efficacy and long-term toxicity. Haematologica 2000;85:1032-1039.
8. 8. Solt I, Gaitini D, Pery M, Hochberg Z, Stein M, Arush MW. Comparing thyroid ultrasonography to thyroid function in long-term survivors of childhood lymphoma. Med Pediatr Oncol. 2000;35:35-40. https://doi.org/10.1002/1096-911X(200007)35:1 3.0.CO;2-#

9. 9. Demirkaya M, Sevinir B, Sağlam H, et al. Thyroid functions in long-term survivors of pediatric Hodgkin’s lymphoma treated with chemotherapy and radiotherapy. J Clin Res Pediatr Endocrinol. 2011;3(2):89-94. https://doi.org/10.4274/jcrpe.v3i2.18
10. 10. Inskip PD, Veiga LHS, Brenner AV, Sigurdson AJ, Ostroumova E, Chow EJ, Stovall M, Smith SA, Weathers RE, Leisenring W, Robison LL, Armstrong GT, Sklar CA, Lubin JH. Hypothyroidism after Radiation Therapy for Childhood Cancer: A Report from the Childhood Cancer Survivor Study. Radiat Res. 2018 Aug;190(2):117-32. Epub 2018 May https://doi.org/10.1667/RR14888.1
11. 11. Rodriquez DC, Guidoni E, D’ambrosio A, Pochiero F, Caini M, Guglielmucci D, Lucherini M, Carra F, Municchi G. Abnormalities of the thyroid in survivors of childhood Hodgkin’s disease. Minerva Pediatr. 2014 Aug; 66(4):249-56.
12. 12. Hakvoort-Cammel FG, Buitendijk S, van den HeuvelEibrink MM, Hahlen K. Treatment of pediatric Hodgkin disease avoiding radiotherapy: excellent outcome with the Rotterdam-HD-84-protocol. Pediatr Blood Cancer 2004;43:8-16. https://doi.org/10.1002/pbc.20031
13. 13. Metzger ML, Hudson MM, Somes GW, Shorr RI, Li CS, Krasin MJ. White race as a risk factor for hypothyroidism after treatment for pediatric Hodgkin’s lymphoma. J Clin Oncol. 2006;24(10):1516-21. https://doi.org/10.1200/JCO.2005.05.0195
14. 14. Constine LS, Donaldson SS, McDougall IR, et al. Thyroid dysfunction after radiotherapy in children with Hodgkin disease. Cancer 1984;53:878-83. https://doi.org/10.1002/1097-0142(19840215)53: 43.0.CO;2-J
15. 15. Kilickap S, Barista I, Ulger S, Celik I, Selek U, Güllü I, Yildiz F, Kars A, Ozisik Y, Tekuzman G. Long-term complications in Hodgkin’s lymphoma survivors. Tumori. 2012 Sep-Oct;98(5):601-6. https://doi.org/10.1177/030089161209800510
16. 16. Meadows AT, Friedman DL, Neglia JP, Mertens AC, Donaldson SS, Stovall M, Hammond S, Yasui Y, Inskip PD. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009;27:2356-62. https://doi.org/10.1200/JCO.2008.21.1920
17. 17. Bhatia S, Blatt J, Meadows AT. Late effects of childhood cancer and its treatment. In: Pizzo PA, Poplack DG (eds). Principles and practice of pediatric oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2006. p.1490-514.
18. 18. Gleeson HK, Shalet SM. Endocrine complications of neoplastic diseases in children and adolescents. Curr Opin Pediatr. 2001;13(4):346-51. https://doi.org/10.1097/00008480-200108000-00011
19. 19. Metzger ML, Howard SC, Hudson MM, Gow KW, Li CS, Krasin MJ, et al. Natural history of thyroid nodules in survivors of pediatric Hodgkin lymphoma. Pediatr Blood Cancer 2006;46(3):314-9.s https://doi.org/10.1002/pbc.20541
20. 20. Crom DB, Kaste SC, Tuburgen DG, et al. Ultrasonography for thyroid screening after head and neck irradiation in childhood cancer survivors. Medical Pediatric Oncology 1997;28:15- 21.Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin’s disease. N Engl J Med. 1991;325:599-605. https://doi.org/10.1056/NEJM199108293250902
21. 22. Solt I, Gaitini D, Pery M, Hochberg Z, Stein M, Arush MW. Comparing thyroid ultrasonography to thyroid function in long-term survivors of childhood lymphoma. Med Pediatr Oncol. 2000;35:35-40. https://doi.org/10.1002/1096-911X(200007)35:1 3.0.CO;2-#
22. 23. Hudson MM, Greenwald C, Thompson E, Wilimas J, Marina N, Fairclough D, Kauffman W, Bozeman P, Mackert PW, Abromowitch M et al. Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin’s disease. J Clin Oncol. 1993; 11:100-8. https://doi.org/10.1200/JCO.1993.11.1.100
23. 24. van Beek RD, van den Heuvel-Eibrink MM, HakvoortCammel FG, van den Bos C, van der Pal HJ, Krenning EP, de Rijke YB, Pieters R, de Muinck Keizer-Schrama SM. Bone mineral density, growth and thyroid function in long-term survivors of pediatric Hodgkin’s lymphoma treated with chemotherapy only. J Clin Endocrinol Metab. 2009;94:1904-9. https://doi.org/10.1210/jc.2008-0622
24. 25. Bhatia S, Yasui Y, Robison LL, et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin’s disease: report from the Late Effects Study Group. J Clin Oncol. 2003;21:4386-94. https://doi.org/10.1200/JCO.2003.11.059
25. 26. Chowdhry AK, Fung C, Chowdhry VK, Bergsma D, Dhakal S, Constine LS, Milano MT. A population-based study of prognosis and survival in patients with second primary thyroid cancer after Hodgkin lymphoma. Leuk Lymphoma. 2018 May;59(5):1180-7.
26. 27. Sigurdson AJ, Ronckers CM, Mertens AC, Stovall M, Smith SA, Liu Y, et al. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study. Lancet. 2005;365:2014-23. https://doi.org/10.1016/S0140-6736(05)66695-0
27. 28. Dörffel W, Riepenhausenl M, Lüders H, Brämswig J, Schellong G. Secondary Malignancies Following Treatment for Hodgkin’s Lymphoma in Childhood and Adolescence. Dtsch Arztebl Int. 2015 May 1; 112(18):320-7. https://doi.org/10.3238/arztebl.2015.0320
28. 29. Sigurdson AJ, Ronckers CM, Mertens AC, Stovall M, Smith SA, Liu Y, et al. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study. Lancet. 2005;365:2014-23. https://doi.org/10.1016/S0140-6736(05)66695-0
29. 30. O’Brien MM, Donaldson SS, Balise RR, Whittemore AS, Link MP. Second malignant neopplasms in survivors of pediatric Hodgkin’s lymphoma treated with low-dose radiation and chemotherapy. J Clin Oncol. 2010; 28:1232-9. https://doi.org/10.1200/JCO.2009.24.8062
30. 31. Ron E, Modan B, Preston D, Alfandary E, Stovall M, Boice JD Jr. Thyroid neoplasia following low-dose radiation in childhood. Radiat Res. 1989;120(3):516-31. https://doi.org/10.2307/3577801
31. 32. Tonorezos ES, Barnea D, Moskowitz CS, Chou JF, Sklar CA, Elkin EB, Wong RJ, et al. Screening for thyroid cancer in survivors of childhood and young adult cancer treated with neck radiation. J Cancer Surviv. 2017 Jun;11(3):302-8. https://doi.org/10.1007/s11764-016-0588-6